Nitric Acid

Nitric Acid

SCHEMBL8957397

O=[N+]([O-])O.O=[N+]([O-])O.OC[C@@H]1CCCC[C@H]1CO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
PABPC1 P11940 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
GSR P00390 2/20 0.34
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL8957432 1.00 CA5A (0.40) CA5ACA5BTDP1PABPC1APOBEC3A
SCHEMBL12606783 0.84 TDP1 (0.35) TDP1PABPC1APOBEC3AAPOBEC3GGSR
SCHEMBL12606786 0.84 TDP1 (0.35) TDP1PABPC1APOBEC3AAPOBEC3GGSR
SCHEMBL44781 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL130805 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL12816270 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL33424 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL130804 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL129425 0.81 TDP1 (0.50) TDP1PABPC1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL12606821 0.79 TDP1 (0.32) TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP disclosed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO disclosed